Novozymes A/S: financial analysis
Ratios worked out from 5 fiscal years of Novozymes A/S's statements, compared with 94 companies in Chemicals.
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | 2022 | 2016 | 2015 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Equity share of assets | 67.1% | 65.5% | — | — | — | 48.9% | 77% |
Efficiency#
| Fiscal year | Trend | 2025 | 2024 | 2022 | 2016 | 2015 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|---|---|
| Asset turnover | — | — | 0.62× | — | — | 0.69× | — |
How each figure is worked out#
- Equity share of assets
- Shareholders' equity as a share of total assets.
- Asset turnover
- Revenue divided by total assets (average of the year).